Study of Multimodal Fascial Plane Blocks to Reduce Pain and Opioid Use After Coronary Artery Bypass Surgery

What this Trial Is About

Postoperative pain after coronary artery bypass grafting CABG through median sternotomy is a significant issue linked to increased opioid use and complications. Researchers are evaluating whether a multimodal fascial plane block package, including bilateral superficial parasternal block, bilateral serratus anterior plane block, and adductor canal block, can improve pain control and reduce opioid consumption in patients undergoing elective isolated CABG with saphenous vein graft harvesting. In this randomized controlled trial, adult patients aged 18 to 80 years scheduled for elective isolated CABG will be assigned to one of two groups. One group will receive the multimodal fascial plane block package following induction of general anesthesia and before surgical incision, along with standard perioperative analgesia. The other group will receive standard perioperative and postoperative analgesia without regional blocks. All other care will be standardized. Participants will be monitored for total opioid consumption within the first 48 hours after surgery, pain scores at 6, 12, 24, and 48 hours, time to first opioid requirement, extubation time, and incidence of postoperative pulmonary complications and atrial fibrillation. Lengths of ICU and hospital stay and time to first mobilization will also be recorded. The study aims to assess whether this multimodal block approach improves postoperative analgesia and clinical outcomes after CABG surgery.

Multimodal Fascial Plane Block for Postoperative Analgesia in Isolated CABG Surgery